Read + Share
Kim ST, Smith SA, Mortimer P, Loembe AB, et al. Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in
Combination with Weekly Paclitaxel in Refractory Cancer. Clin Cancer Res 2021;27:4700-4709.
PMID: 33975862
|
 |
|
Kim ST, Smith SA, Mortimer P, Loembe AB, et al. Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in
Combination with Weekly Paclitaxel in Refractory Cancer. Clin Cancer Res 2021;27:4700-4709.
PMID: 33975862
|
|
|
|